Document:

SHARE PURCHASE AND OPTION AGREEMENT

This Share Purchase Agreement is made
as of the 16th day of June, 2016, between:

NICK BOZZA, as applicable
in his personal capacity and as nominee for the Nick Bozza Family Trust (the “Vendor”)

– and –

EVENT CARDIO GROUP INC. (the
“Company”)

– and –

EVENT CARDIO CANADA INC. (“EC
Canada”)

- and -

9058583 CANADA INC. (“905”)

– and –

2419596 ONTARIO INC. (“241”)

– and –

8401144 CANADA INC. (“840”)

– and –

2399371 ONTARIO INC. (“239”)

– and –

GIANFRANCO (aka John) BENTIVOGLIO
and

FRANK SGRO and

THE BENTIVOGLIO FAMILY TRUST and

THE SGRO FAMILY TRUST and

TAUNTON RAVENSCROFT INC.

(collectively, the “John and Frank Parties”)

(the Company, EC Canada, 905, 241,
840, 239 and the John and Frank Parties together, the “ECG Parties”, and each, an “ECG Party”)

    	 	

	 

    	 

    

RECITALS:

		A.	The
                                         Vendor is the registered and beneficial owner, as applicable in his personal capacity
                                         and as nominee for the Nick Bozza Family Trust, of:

		(I)	29,812,500
                                         shares of common stock in the capital of the Company (the “Bozza ECG Shares”);

		(II)	450 common
                                         shares in the issued and outstanding capital of 840 (the “Bozza 840 Shares”);

		(III)	375 common
                                         shares in the capital of 241 (the “Bozza 241 Shares”); and

		(IV)	1,000 common
                                         shares in the capital of 905 (the “Bozza 905 Shares”).

		B.	One
                                         or more of the John and Frank Parties, directly and/or indirectly, hold and control,
                                         in the aggregate:

		(I)	approximately
                                         49 million shares of common stock in the capital of the Company;

		(II)	the
                                         other 450 common shares in the issued and outstanding capital of 840;

		(III)	the
                                         other 625 common shares in the issued and outstanding capital of 241;

		(IV)	the
                                         other 2,000 common shares in the issued and outstanding capital of 905; and

		(V)	all
                                         of the issued and outstanding capital of 239.

		C.	The
                                         Company is the direct 100% parent of EC Canada.

		D.	The
                                         Vendor has advanced certain shareholder loans to the Company in the aggregate amounts
                                         of CDN$36,889.00 and US$13,548.32 (the “Bozza Advances”).

		E.	Pursuant
                                         to that certain promissory note dated the 22nd day of October, 2014, 905 was
                                         indebted to 239 in the aggregate amount of CDN$79,106 (the “239 Debt”)
                                         and as additional security for the 239 Debt and pursuant to that certain share pledge
                                         agreement made as of the 22nd day of October, 2014, the Vendor pledged the
                                         Bozza 905 Shares to and in favour of 239 (the “239 Pledge”). 239 assigned
                                         the 239 Debt to the Company by assignment dated December 18, 2015 (the “239 Assignment”).

		F.	The
                                         Vendor and each of the ECG Parties (other than 840 and 239) are parties to the Minutes
                                         of Settlement signed on the 6th day of May, 2016 (the “Minutes”)
                                         which provide for, among other things,

		(I)	the
                                         sale by the Vendor to the Company, or as the Company may direct, of:

		(1)	20,000,000
                                         of the Bozza ECG Shares;

		(2)	the
                                         Bozza 840 Shares;

		(3)	the
                                         Bozza 241 Shares; and

		(4)	the
                                         Bozza 905 Shares,

(collectively,
the “Purchased Shares”) as well as the repayment by the Company to the Vendor of the Bozza Advances, in each
case on an “as is, where is” basis and for aggregate cash consideration payable jointly and severally by the Company,
840 and 905 to the Vendor of CDN$1,025,000; and

		(II)	the
                                         grant by the Vendor to the Company of an option, exercisable in whole and not in part
                                         by the Company at any one time on or before May 6, 2018, to purchase from the Vendor
                                         the remainder 9,812,500 of the Bozza ECG Shares (the “Option Shares”)
                                         on an “as is, where is” basis for cash consideration of US$500,000 (the “Option”).

NOW
THEREFORE in consideration of the mutual covenants and agreements contained in this Agreement and other good and valuable
consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties agree as follows:

    	 	

	 

    	 

    

Section 1
– INTERPRETATION

		1.1	Definitions

In this
Agreement, in addition to the defined terms elsewhere herein:

		(1)	“Agreement”
                                         means this Share Purchase and Option Agreement;

		(2)	“Closing”
                                         means the successful completion of the purchase and sale of the Purchased Shares and
                                         the repayment of the Bozza Advances as contemplated in Section 5;

		(3)	“Encumbrances”
                                         means any security interest (whether contractual, statutory or otherwise), hypothec,
                                         mortgage, trust or deemed trust (whether contractual, statutory or otherwise), lien,
                                         mortgage, execution, levy, pledge, charge or other financial or monetary claim, real
                                         property license, assignment, encumbrance, option, right, privilege or any adverse claim
                                         of any nature or kind whatsoever, whether or not it has attached or been perfected, registered
                                         or filed, whether secured, unsecured or otherwise;

		(4)	“Escrow
                                         Agent” means Goodmans LLP;

		(5)	“Escrow
                                         Agreement” has the meaning set out in Section 3.2.

		(6)	“Governmental
                                         Authority” means any Canadian or U.S. federal, provincial, state, municipal
                                         or local, or any foreign government, governmental, regulatory or administrative authority,
                                         agency or commission or any court, tribunal, or judicial or arbitral body or any other
                                         public agency;

		(7)	“Mutual
                                         Release” has the meaning set out in Section 3.1;

		(8)	“Parties”
                                         means the Vendor and the ECG Parties and “Party” means any of them;

		(9)	“Purchase
                                         Price” has the meaning set out in Section 5.1; and

		(10)	“Transaction”
                                         means the transactions contemplated in this Agreement, including the Release and the
                                         Escrow Agreement contemplated in Section 2, the sale and purchase of the Purchased
                                         Shares, the repayment of the Bozza Advances, the granting of the Option and the exercise
                                         of the Option.

		1.2	Interpretations.

		(1)	The
                                         division of this Agreement into sections and the insertion of headings are for convenience
                                         of reference only and shall not affect the construction or interpretation of this Agreement.

		(2)	The
                                         terms “this Agreement”, “hereof”, “herein” and “hereunder”
                                         and similar expressions refer to this Agreement and not to any particular section hereof.

		(3)	Unless
                                         the context otherwise requires, words importing the singular include the plural and vice
                                         versa and words importing gender include all genders.

		(4)	Every
                                         use of the words “including” or “includes” in this Agreement
                                         is to be construed as meaning “including, without limitation” or “includes,
                                         without limitation”, respectively.

    	 	

	 

    	 

    

Section 2
– RELEASE AND TERMINATION OF 239 PLEDGE AND 239 DEBT

		2.1	Cancellation
                                         and Termination

Each
of the Company, 239 and the John and Frank Parties hereby irrevocably and unconditionally acknowledges and agrees that all agreements,
documents or other instruments evidencing, representing or comprising any and all liabilities and obligations of the Vendor under,
in relation to or in respect of the 239 Debt, including the 239 Pledge, are each hereby cancelled and terminated and are of no
further force and effect.

		2.2	Release
                                         and Discharge

Each
of the Company, 239 and the John and Frank Parties hereby irrevocably and unconditionally:

		(1)	forever
                                         releases and discharges and re-assigns to the Vendor and his successors and assigns,
                                         all of his right, title, interest, benefit and all Encumbrances which any one or more
                                         of them has or had against, in and/or to all of the Vendor’s property, assets,
                                         rights and undertaking, real and personal, moveable and immoveable, of whatsoever nature
                                         and kind, including in the Bozza 905 Shares;

		(2)	grants,
                                         releases, remises, reconveys, transfers, assigns, discharges and forever quitclaims and
                                         surrenders to the Vendor and his successors and assigns, all of the assets, properties
                                         and undertakings of any kind or manner of the Vendor now covered or intended to be covered
                                         by the Encumbrances granted to any of them to have and to hold all said assets, properties
                                         and undertakings forever and absolutely freed, acquitted, discharged and released of
                                         and from all Encumbrances, including the 239 Debt and the 239 Pledge, and from the obligations,
                                         principal monies, interest and other monies whatsoever thereby secured and every trust,
                                         proviso, covenant, matter and thing therein contained;

		(3)	represents,
                                         warrants and covenants that it has the power and capacity to enter into this Agreement
                                         on its own behalf and that save for the 239 Assignment, none of the benefit of any of
                                         the 239 Debt, the 239 Pledge or any agreement, instrument, document, pledge, security
                                         interest or other encumbrance or lien, or any registration made in respect thereof has
                                         been assigned; and

		(4)	as
                                         applicable, acknowledges and consents to all of the foregoing as a debtor, co-guarantor
                                         or other obligor of the 239 Debt, and that all agreements, documents or other instruments
                                         evidencing, representing or comprising any and all liabilities and obligations of the
                                         Vendor under, in relation to or in respect of the 239 Debt, including the 239 Pledge,
                                         are each hereby cancelled and terminated and are of no further force and effect.

Section 3
– MUTUAL RELEASE AND ESCROW AGREEMENT

		3.1	Mutual
                                         Release

Concurrently
with, and as a condition to, the Closing, the Parties shall have executed and delivered to each other a comprehensive mutual release
as contemplated in the Minutes, substantially in the form attached hereto as Schedule “A” (the “Mutual Release”).

		3.2	Escrow
                                         Agent

Concurrently
with, and as a condition to, the Closing, the Vendor, the Company and the Escrow Agent shall have executed and delivered to each
other an escrow agreement substantially in the form attached hereto as Schedule “B” (the “Escrow Agreement”).

    	 	

	 

    	 

    

Section 4 – RESIGNATIONS AND RELEASES

		4.1	Resignations
                                         and Releases

Effective
upon the date hereof:

		(1)	The
                                         Vendor shall resign or shall have resigned each of the Vendor’s positions as a
                                         director, officer and employee of each of the Company, 241, 905, 840 and EC Canada.

		(2)	All
                                         existing employment, consulting and other similar agreements and arrangements, written,
                                         oral or otherwise, between the Vendor, on the one hand, and any one or more of the ECG
                                         Parties, on the other hand, shall be and be deemed to be automatically terminated without
                                         any further act or otherwise from or on behalf of any Party, and each Party hereby irrevocably
                                         and unconditionally confirms and agrees that effective from and after the date hereof,
                                         no such agreement or arrangement shall be or deemed to be of any further force or effect.

		(3)	For
                                         certainty and without limiting the foregoing, each Party hereby irrevocably and unconditionally
                                         waives any rights that each had, has or may have pursuant to any employment, consulting
                                         and other similar agreements and arrangements, including all rights with respect to notice
                                         of termination, resignation or severance.

		4.2	Records
                                         and Filings

		(1)	Prior
                                         to or promptly upon Closing, each of the Company, 241, 905, 840 and EC Canada shall ensure
                                         that all requisite documents, notices and other filings, including in respect of their
                                         respective corporate records and minute books and all public corporate and securities
                                         filings required by law, to reflect the resignation of the Vendor as a director and/or
                                         officer thereof shall have been completed and filed with all applicable Governmental
                                         Authorities.

		(2)	Without
                                         limiting the generality of Section 4.1(2), at or prior to the date hereof, each
                                         of the Company, 241, 905, 840 and EC Canada shall duly complete and sign:

		(a)	Business
                                         Corporations Act (Ontario) Form 1’s for 241 and EC Canada;

		(b)	Canada
                                         Business Corporations Act Form 6’s for 905 and 840; and

		(c)	applicable
                                         corporate, securities and stock exchange filings for the Company,

and
in the case of the forms required by Sections 4.2(2)(a) and 4.2(2)(b), deliver same to the Vendor upon Closing authorizing
and allowing the Vendor to have same filed with the applicable Governmental Authority, and the Vendor shall promptly file same
and provide evidence of same, and in the case of the forms required by Section 4.2(2)(c), promptly file same with the applicable
Governmental Authority upon Closing and provide evidence of same.

Section 5
– PURCHASE AND SALE OF SHARES AND REPAYMENT

		5.1	Purchase
                                         and Sale and Repayment

Subject
to the terms and conditions hereof, including the effectiveness and enforcement of Section 2, the Vendor hereby sells and
transfers all of the Vendor’s right, title and interest in and to the Purchased Shares, free and clear of all Encumbrances,
to the Company and as the Company hereby directs as follows:

		(a)	to
                                         the Company, 20,000,000 of the Bozza ECG Shares;

		(b)	to
                                         840, the Bozza 840 Shares;

		(c)	to
                                         the Company, the Bozza 241 Shares; and

		(d)	to
                                         905, the Bozza 905 Shares,

    	 	

	 

    	 

    

and
the Company, 840 and 905 hereby purchases and receives for cancellation from the Vendor their respective Purchased Shares, in
each case on an “as is, where is” basis, and the Company hereby also repays to the Vendor the Bozza Advances, for
aggregate cash consideration payable jointly and severally by the Company, 840 and 905 to the Vendor of CDN$1,025,000 (the “Purchase
Price”).

		5.2	Purchase
                                         Price Payment

The
Company, 840 and 905 shall jointly and severally pay the Purchase Price to the Vendor, or as the Vendor may direct, concurrently
with their execution and delivery of this Agreement to the Vendor by wire transfer of immediately available funds to such bank
account as is designed by the Vendor prior to or on the date hereof.

		5.3	Delivery
                                         of Purchased Shares and Instructions

To complete
the purchase and sale contemplated in this Section 5 and subject to its receipt of the Purchase Price in immediately available
funds, the duly executed and delivered Mutual Release, the duly executed and delivered Escrow Agreement and the duly completed
and signed forms contemplated in Section 4.2:

		(a)	promptly
                                         upon Closing, together with the documents to be delivered by the Purchaser to the Vendor
                                         at Closing pursuant to Section 5.3(c), the Vendor shall deliver or cause to be delivered
                                         to the Company’s transfer agent the original certificate in the Vendor’s
                                         possession and control representing the Bozza ECG Shares, duly endorsed (with signature
                                         guarantee) with irrevocable written instructions to (i) return to the Company and
                                         cancel the 20,000,000 Bozza ECG Shares and (ii) issue a new original certificate
                                         for the Option Shares and to deliver same to the Escrow Agent;

		(b)	at
                                         the Closing, the Vendor shall deliver to the Company forms of transfer to transfer the
                                         Bozza 241 Shares, the Bozza 840 Shares and the Bozza 905 Shares to the Company, 840 and
                                         905, respectively, it being acknowledged and confirmed by the ECG Parties that the original
                                         share certificates representing such Purchased Shares are in the corporate minute books
                                         of 241, 840 and 905, all of which are in the possession and control of the ECG Parties;
                                         and

		(c)	the
                                         Purchaser shall deliver to the Vendor, for onward delivery to the Company’s transfer
                                         agent pursuant to Section 5.3(a), in each case to the satisfaction of the Company’s
                                         transfer agent:

			

	(i)	 	a
                                         Board of Directors’ Resolution authorizing the return and cancellation of the 20,000,000
                                         Bozza ECG Shares to the Company’s authorized shares and that authorizes the hold
                                         harmless form;
	(ii)		the
                                         Hold Harmless Rescission on Company letterhead with an authorized signature; and

	(iii)		fees/confirmation
                                         that this request is to be billed to the Company.

		5.4	Allocation
                                         of Purchase Price

The
Parties agree that the Purchase Price shall be allocated as follows:

		(a)	CDN$36,889.00
                                         and (CDN$ equivalent of) US$13,548.32 to the Bozza Advance;

		(b)	CDN$50.00
                                         in respect of the Bozza 840 Shares;

		(c)	CDN$37.50
                                         in respect of the Bozza 241 Shares; and

		(d)	CDN$1.00
                                         in respect of the Bozza 905 Shares; and

		(e)	the
                                         remainder in respect of the 20,000,000 Bozza ECG Shares.

    	 	

	 

    	 

    
		5.5	“As
                                         Is, Where Is”

Each
of the Company, 840 and 905 acknowledges and agrees that all of the Purchased Shares and, as applicable, the Option Shares,
are purchased on an “as is, where is” basis and that the Company, 840 and 905 will each accept all of their respective
Purchased Shares and, as applicable, the Option Shares, as they exist on the date hereof and thereof. Except as otherwise specifically
stated herein in Section 7.1 only, no representation, warranty or condition, whether statutory, express or implied, oral
or written, legal, equitable, conventional, collateral or otherwise is being given by the Vendor in this Agreement or in any instrument
furnished in connection with this Agreement, including as to: (i) the condition, value, fitness for purpose or marketability
of the Purchased Shares or the Option Shares; (ii) any consents, approvals, licenses, registrations or conditions required
by any Governmental Authority in respect of or pertaining to any of the Purchased Shares, the Option, the Option Shares or the
Transactions; and (iii) any other matter or thing whatsoever in respect of or pertaining to the Purchased Shares, the Option,
the Option Shares or the Transaction. The Company, 840 and 905 each further acknowledges, confirms and agrees that it has, and
shall be deemed to have, relied entirely on its own inspection and investigation in proceeding with the Transaction and the Option
and shall have no recourse, directly or indirectly, against the Vendor or its affiliates or any of the property or assets of the
Vendor or its affiliates.

		5.6	Taxes

The Parties hereby
agree that the Company, 840 and 905, collectively, are solely liable and responsible for, and shall pay when due, all applicable
federal and provincial taxes (other than taxes in respect of income) that may be exigible in connection with the Transaction and
the exercise of the Option and purchase of Option Shares, as applicable. The Company, 840 and 905 jointly and severally agree
to indemnify and save the Vendor, its affiliates and associates, and their respective successors and assigns, harmless from and
against all claims and demands for payment of any such applicable taxes, including any liability or costs incurred as a result
of any failure by the Company, 840 and/or 905 to pay such taxes when due.

Section 6
– OPTION

		6.1	Option
                                         Shares

		(1)	The
                                         Vendor hereby grants to the Company the non-transferable and non-assignable right to
                                         purchase for cancellation from the Vendor, on the same terms, conditions and limitations
                                         (including on an “as is, where is” basis) as applicable to the Purchased
                                         Shares, all but not less than all of the Option Shares for US$500,000.00, exercisable
                                         by the Company at any one time from the date hereof to the end of business on May 6,
                                         2018.

		(2)	At
                                         the Closing, subject to its receipt of the Purchase Price in immediately available funds,
                                         a duly executed and delivered Mutual Release, the duly executed and delivered Escrow
                                         Agreement and the duly completed and signed forms contemplated in Section 4.2, the
                                         Vendor shall deliver to the Company’s transfer agent the irrevocable written instructions
                                         pursuant to in Section 5.3(a) and to the Escrow Agent a form of transfer executed
                                         (with signature guarantee) in blank for the Option Shares.

		(3)	Notwithstanding
                                         the deposit into escrow as provided in Section 6.1(2), unless and until the Option
                                         has been exercised in strict compliance with this Section 6 and the Option Shares
                                         have been purchased by the Company for cancellation, the Vendor remains the sole beneficial
                                         holder of the Option Shares and shall retain all rights in connection therewith, including
                                         the right to vote and attend meetings and all other rights as a holder of the Company’s
                                         common stock.

		(4)	Notwithstanding
                                         any other term or condition in this Agreement, the Option and all rights, interests and
                                         benefit therein, and the obligations of the Vendor thereunder, shall not be transferrable
                                         or assignable, and, unless the Vendor has provided his written consent in advance, in
                                         the Vendor’s sole and absolute discretion, shall only be exercisable directly by
                                         the Company in strict compliance with this Section 6.

		(5)	None
                                         of the Vendor, its affiliates and associates, its and their agents, representatives and
                                         advisors and their respective successors and assigns shall be liable to the Company or
                                         any other ECG Party for any loss resulting from (1) a decline in the market value
                                         of any Option Shares or (2) any change in the market price of the Option Shares
                                         between the date of grant and the time of purchase of the Option Shares pursuant to this
                                         Section 6.

    	 	

	 

    	 

    
		6.2	Option
                                         Exercise

		(1)	The
                                         Option shall be exercised by the Company’s delivery to the Vendor and the Escrow
                                         Agent of an irrevocable and unconditional written notice confirming the Company’s
                                         exercise of the Option to purchase for cancellation all of the Option Shares, accompanied
                                         by the payment by wire transfer to the Escrow Agent, in trust, of US$500,000.00 in immediately
                                         available funds.

		(2)	Upon
                                         indefeasible receipt of US$500,000.00 in immediately available funds, the Escrow Agent
                                         shall release from escrow and deliver to the Company the certificate and transfer form
                                         delivered in escrow pursuant to Section 6.1(2), to complete the Company’s
                                         purchase for cancellation of Option Shares, all as set out in the Escrow Agreement.

		6.3	Expiry

Unless
duly exercised by the Company prior to the end of business on May 6, 2018 in full compliance with this Section 6 and
the other applicable terms and conditions of this Agreement and the Escrow Agreement, the Option shall automatically (without
any notice, action or otherwise by or to the Vendor or any ECG Party) terminate, expire and be null and void and of no further
force or effect at the end of business on May 6, 2018 for all of the Option Shares, and the Vendor shall thereafter be entitled
to provide a written direction to the Escrow Agent to release from escrow and return the certificate and transfer form delivered
in escrow pursuant to Section 6.1(2) to the Vendor as the Vendor may direct, in its sole and absolute discretion.

SECTION 7
– REPRESENTATIONS AND WARRANTIES

		7.1	Vendor’s
                                         Representations

The
Vendor represents and warrants to the Company, 840, 241 and 905, and acknowledges that the Company, 840, 241 and 905 are relying
upon such representations and warranties in connection with the purchase and sale of the Purchased Shares and the Option Shares,
as applicable, and the entering into of this Agreement, that:

		(a)	the
                                         Vendor, as applicable in his personal capacity and as nominee for the Nick Bozza Family
                                         Trust, has registered and beneficial ownership of and title to the Purchased Shares;

		(b)	the
                                         Vendor has all necessary power, authority and capacity to enter into this Agreement and
                                         to perform its obligations hereunder;

		(c)	the
                                         execution and delivery of this Agreement and the consummation of the Transaction has
                                         been duly authorized by all necessary action on the part of the Vendor;

		(d)	the
                                         Vendor is not a non-resident of Canada for purposes of the Income Tax Act (Canada);
                                         and

		(e)	this
                                         Agreement constitutes a legal, valid and binding obligation of the Vendor, enforceable
                                         against it in accordance with its terms.

The
Vendor’s representations and warranties contained in this Agreement shall survive the Closing and shall terminate upon the
second (2nd) anniversary of the Closing, provided that the Vendor’s representations and warranties
in this Section 7.1 shall be, and be deemed to be, repeated (as applicable, in respect of the Option exercise and the Option
Shares only) for the completion of the Option exercise and the purchase for cancellation by the Company of the Option Shares and
such representations and warranties (as so repeated or deemed repeated) shall terminate upon the second (2nd) anniversary
of the completion of the purchase for cancellation by the Company of the Option Shares.

    	 	

	 

    	 

    
		7.2	ECG
                                         Parties’ Representations

The
ECG Parties jointly and severally represent and warrant to the Vendor, and acknowledges that the Vendor is relying upon such representations
and warranties in connection with the purchase and sale of the Purchased Shares and the Option Shares, as applicable, and the
entering into of this Agreement, that:

		(a)	each
                                         of the ECG Parties has all necessary corporate power, authority and capacity to enter
                                         into this Agreement and to perform its obligations hereunder

		(b)	the
                                         execution and delivery of this Agreement and the consummation of the Transaction contemplated
                                         herein has been duly authorized by all necessary corporate action on the part of each
                                         of the ECG Parties;

		(c)	this
                                         Agreement constitutes a legal, valid and binding obligation of each of the ECG Parties,
                                         enforceable against each of them in accordance with its terms;

		(d)	save
                                         for the Company, none of the other ECG Parties is a non-resident of Canada for purposes
                                         of the Income Tax Act (Canada);

		(e)	the
                                         Company, 840 and 905 each has unrestricted funds and cash on hand necessary to complete
                                         the Transaction;

		(f)	no
                                         notice, filing, consent, approval, order or authorization of or registration, qualification,
                                         designation, declaration or filing with any Governmental Authority by any Party is required
                                         in connection with the consummation of each aspect of the Transactions;

		(g)	the
                                         Transaction and the purchase for cancellation from the Vendor by each of the Company,
                                         840 and 905 of their respective Purchased Shares and Option Shares, as applicable, pursuant
                                         to this Agreement are in compliance with all applicable Canadian and U.S. securities
                                         laws, regulations, rules, rulings and orders together with applicable published policy
                                         statements, notices, orders, blanket rulings and other regulatory instruments of the
                                         securities regulatory authorities of Canada and the U.S., and no prospectus, registration
                                         statement or similar document, or any other filing, report, notice, certificate or similar
                                         document or instrument need be prepared, delivered or filed prior to, at or upon theClosing
                                         by the Vendor or any other Party, other than any prescribed filings required to be filed
                                         by the Company upon Closing; and

		(h)	each
                                         of the Company, 840 and 905 is an informed and sophisticated purchaser and is experienced
                                         in the evaluation and purchase property and assets such as the Purchased Shares, has
                                         conducted and has had sufficient time and opportunity to conduct, any and all such inspections
                                         and investigations and obtained all such advice (legal, financial and otherwise) concerning
                                         the Purchased Shares as each of them deems appropriate and each has relied solely on
                                         its own inspection and investigations and the advice of its legal counsel in entering
                                         into this Agreement and consummating the Transaction.

The
ECG Parties’ joint and several representations and warranties contained in this Agreement shall survive the Closing and
shall terminate upon the second (2nd) anniversary of the Closing, provided that the Company’s representations
and warranties in this Section 7.2 shall be, and be deemed to be, repeated for the completion of the Option exercise and
the purchase for cancellation by the Company of the Option Shares and such representations and warranties (as so repeated or deemed
repeated) shall terminate upon the second (2nd) anniversary of the completion of the purchase for cancellation by the
Company of the Option Shares.

    	 	

	 

    	 

    

SECTION 8
– GENERAL

		8.1	Further
                                         Assurances

The
Vendor, on the one hand, and each ECG Party, on the other hand, shall each take or cause to be taken such action and shall execute
and deliver or cause to be executed and delivered to the ECG Parties and the Vendor, respectively, such documents and further
assurances (including transfer documents and minute book documents) as may be reasonably necessary or requested by the other to
give effect to this Agreement and the intention and terms and conditions hereof.

		8.2	Specific
                                         Performances

The
Vendor, on the one hand, and each ECG Party, on the other hand, each acknowledges and agrees that the other Party would be damaged
irreparably if any of the provisions of this Agreement are not performed in accordance with their specific terms or otherwise
are breached. Accordingly, each Party agrees that the other Party shall be entitled, without the necessity of pleading or proving
irreparable harm or lack of an adequate remedy at law or posting any bond or other security, to an injunction or injunctions to
prevent breaches of the provisions of this Agreement and to enforce specifically this Agreement and the terms and provisions hereof.

		8.3	Notice

Any
notice or other communication under this Agreement shall be in writing and may be delivered personally or transmitted by electronic
means, addressed as follows:

in
the case of the Vendor, as follows:

4
Coleman Court

Thorold, ON L2V $W3

Telephone
No.:(905) 680-9010 ext. 203

Email:
nbozza1@cogeco.ca

with
a copy to:

Goodmans
LLP

3400 - 333 Bay Street

Toronto, ON M5H 2S7

Attention:Ken
Crofoot

Telephone
No.:(416) 597-4110

Email:
kcrofoot@goodmans.ca

and
in the case of the ECG Parties, as follows:

2798
Thamesgate Drive, #6

Mississauga, ON L4T 4E8

Attention:
John Bentivoglio

Telephone
No.:(289) 407-4377

Email:john@eventcardiogroup.com

with
a copy to:

Capo
Sgro LLP

7050 Weston Road, Suite 400

Woodbridge, ON L4L 8G7

Attention:
Alistair Riswick

Telephone
No.:(905) 850-7000 ext. 262

Email:ariswick@csllp.ca

    	 	

	 

    	 

    
		8.4	Full
                                         Understanding and Independent Legal Advice

By signing
this Agreement, the Vendor, on the one hand, and each ECG Party, on the other hand, each expressly confirms and agrees that: (i) such
Party has had an adequate opportunity to read and consider the terms set out herein, including the Resignation and Termination
in Section 2, and that such Party fully understands each of the terms and provisions herein and therein and their respective
consequences; (ii) such Party has been advised to consult with legal counsel of such Party’s choosing and that such
Party has obtained such legal or other advice as such Party has considered advisable; and (iii) such Party is signing this
Agreement voluntarily, without coercion.

		8.5	Expenses

Each
Party shall pay its respective legal, accounting and other professional advisory fees, costs and expenses incurred in connection
with the negotiation, preparation and execution of this Agreement and all documents and instruments executed or delivered pursuant
to this Agreement, as well as any other fees, costs and expenses incurred.

		8.6	Entire
                                         Agreement and Amendment

This
Agreement and the attached schedules shall constitute the entire agreement between the Parties with respect to the subject matter
and supersede all prior negotiations and understandings other than the Minutes. There are no representations, warranties, terms,
conditions, undertakings or collateral agreements, express, implied or statutory, between the Parties other than as expressly
set forth in this Agreement and the Minutes. This Agreement may not be amended or modified in any respect except by written instrument
executed by the Vendor and the Company.

		8.7	Paramountcy

In the
event of any conflict or inconsistency between the provisions of this Agreement, and any other agreement, document or instrument
executed or delivered in connection with the Transaction, Option exercise or this Agreement, other than the Minutes, the provisions
of this Agreement shall prevail to the extent of such conflict or inconsistency. In the event of any conflict or inconsistency
between the provisions of this Agreement and the Minutes, the provisions of the Minutes shall prevail to the extent of such conflict
or inconsistency.

		8.8	Severability

If any
provision of this Agreement or any document delivered in connection with this Agreement is partially or completely invalid or
unenforceable, the invalidity or unenforceability of that provision shall not affect the validity or enforceability of any other
provision of this Agreement, all of which shall be construed and enforced as if that invalid or unenforceable provision were omitted.
The invalidity or unenforceability of any provision in one jurisdiction shall not affect such provision’s validity or enforceability
in any other jurisdiction.

		8.9	Enurement
                                         and Assignment

This
Agreement shall enure to the benefit of and be binding upon the Parties hereto and their respective successors and permitted assigns,
provided that this Agreement shall not be assignable or assigned without the prior written consent of the Vendor and the Company.

    	 	

	 

    	 

    
		8.10	Governing
                                         Law

This
Agreement and matters arising in connection with this Agreement shall be governed by and construed in accordance with the laws
of the Province of Ontario and the federal laws of Canada applicable therein. Each Party hereto irrevocably and unconditionally
submit to the jurisdiction of the courts in the Province of Ontario in connection with any matter arising from the Minutes or
this Agreement, including the specific performances remedies in Section 8.2

		8.11	Counterparts

This
Agreement may be executed in any number of counterparts, each of which shall be deemed to be an original and all of which shall
constitute one and the same agreement. Transmission by electronic means of an executed counterpart of this Agreement shall be
deemed to constitute due and sufficient delivery of such counterpart.

[Remainder
of page intentionally left blank]

    	 

    	 

    

IN
WITNESS WHEREOF the Parties have duly executed this Agreement as of the date first written above. 

	 	 	/s/ Nick Bozza
	Witness	NICK
    BOZZA

 

	 	 	THE
    BOZZA FAMILY TRUST
	Per:	/s/ Nick
    Bozza
	 	Name:
	 	Title:

         

	 	 	I/we
    have the authority to bind the corporation.

 

	 	 	EVENT
    CARDIO GROUP INC.
	Per:	s/ John
    Bentivoglio
	 	Name: John Bentivoglio
	 	Title:President
	 	 
	 	 	I/we
    have the authority to bind the corporation.

 

	 	 	EVENT
    CARDIO (CANADA) INC.
	Per:	/s/
    John Bentivoglio
	 	Name: John Bentivoglio
	 	Title:President
	 	 	I/we
    have the authority to bind the corporation.

 

	 	 	9058583
    CANADA INC.
	Per:	s/
    John Bentivoglio
	 	Name: John Bentivoglio
	 	Title: President
	 	 	I/we
    have the authority to bind the corporation.

 

    	 	

	 

    	 

    

	 	 	2419596
    ONTARIO INC.
	Per:	/s/
    John Bentivoglio
	 	Name: John Bentivoglio
	 	Title:President
	 	 	I/we
    have the authority to bind the corporation.

 

	 	 	8401144
    CANADA INC.
	Per:	/s/
    John Bentivoglio
	 	Name:John Bentivoglio
	 	Title:President
	 	 	I/we
    have the authority to bind the corporation.

 

	 	 	2399371
    ONTARIO INC.
	Per:	/s/
    Frank Sgro
	 	Name: Frank Sgro
	 	Title:President
	 	 	I/we
    have the authority to bind the corporation.

	/s/ Cassie Chan	 	/s/
    John Bentivoglio
	Witness	GIANFRANCO
    (aka John) BENTIVOGLIO

 

	/s/ Cassie Chan	 	/s/
    Frank Sgro
	Witness	FRANK
    SGRO

 

	 	 	THE
    BENTIVOGLIO FAMILY TRUST
	Per:	/s/ John
    Bentivoglio
	 	Name:Gianfranco
    (aka John) Bentivoglio
	 	Title:Trustee

 

	 	 	THE
    SGRO FAMILY TRUST
	Per:	/s/ Frank
    Sgro
	 	Name:Frank Caruso
    Sgro
	 	Title:Trustee

 

	 	 	TAUNTON
    RAVENSCROFT INC.
	Per:	/s/
    Frank Sgro
	 	Name:Frank Caruso
    Sgro
	 	Title:President
    
	 	 	I/we
    have the authority to bind the corporation.

 

    	 

    	 

    

SCHEDULE “A”

FORM OF MUTUAL RELEASE

 

 

 

 

    	 

    	 

    

SCHEDULE “B”

FORM OF ESCROW AGREEMENTSUBSCRIPTION AGREEMENT

 

This Subscription Agreement dated as
of June , 2016 (the “Agreement”), is entered into between Zhenli Xu (the “Subscriber”),
and Event Cardio Group Inc., a Nevada corporation (the “Company”)

 

Preliminary Statement

 

Subscriber desires
to purchase, and the Company is willing to sell to the Subscriber, upon the terms and conditions stated in this Agreement, 2,500,000
shares (the “Shares”) of its common stock, par value $0.001 per share (the “Common Stock”), together with
warrants (the “Warrants”) to purchase an additional 833,333 shares of common stock (“the “Warrant Shares”),
for a total purchase price of $(US) 375,000 (the “Purchase Price”). The Warrants, in the form annexed hereto as Exhibit
A, may be exercised for a period commencing on the date of issuance and ending on December 31, 2019, at an initial exercise price
of $US 0.25 per share. The Shares, Warrants and shares of Common Stock issuable upon exercise of the Warrants (the “Warrant
Shares”) are referred to collectively herein as the “Securities.”

 

The Company and
the Subscriber are executing and delivering this Agreement in reliance upon the exemption from securities registration afforded
by Regulation S, as promulgated by the United States Securities and Exchange Commission under United States Securities Act of
1933, as amended (the “Securities Act”).

 

NOW, THEREFORE,
in consideration of the premises and mutual covenants and agreements hereinafter set forth, and intending to be legally bound,
the parties hereby agree as follows:

 

ARTICLE I

PURCHASE OF SECURITIES

 

Section 1.1 Purchase
of the Securities. Subject to the terms and conditions of this Agreement, the Subscriber agrees to purchase from the Company,
and the Company agrees to issue and sell to the Subscriber, the Shares and Warrants for the Purchase Price.

 

Section 1.2 Payment.
Payment of the Purchase Price shall be made on or before June 17, 2016 by wire transfer of immediately available funds to an account
designated by the Company. Upon receipt of payment the Company will deliver to the Subscriber one or more certificates evidencing
the Warrants and instruct its transfer agent to deliver to the Subscriber promptly thereafter one or more certificates evidencing
the Shares. The Company shall have the right to terminate this Agreement if it has not received the Purchase Price by June 17,
2016, in which case this Agreement shall have no further force or effect, and the Company shall have no obligation to issue the
Shares or Warrants.

 

 

 

ARTICLE II

REPRESENTATIONS AND WARRANTIES OF THE COMPANY

 

The Company represents
and warrants to the Subscriber that:

 

Section 2.1 Organization,
Good Standing and Authority. The Company is a corporation duly incorporated, validly existing and in good standing under the
laws of the State of Nevada and has the requisite corporate power and authorization to own its properties and to carry on its
business as now being conducted.

 

Section 2.2 Due Execution and
Delivery; Valid and Binding Agreement. The execution and delivery of this Agreement by the Company and the consummation by
it of the transactions contemplated hereby have been duly authorized by the Company’s Board of Directors and no further
consent or authorization of the Company, its Board of Directors, or its shareholders is required.  This Agreement has been duly
executed and delivered by the Company and constitutes a legal, valid and binding obligation of the Company enforceable against
the Company in accordance with its terms.

 

    	 	

	 

    	 

    

Section 2.3 Issuance
of Securities. The issuance of the Securities in accordance with the terms of this Agreement has been duly authorized and,
upon issuance in accordance with the terms hereof, shall be validly issued and free from all taxes, liens and charges with respect
to the issue thereof and the Shares, and the Warrant Shares issuable upon exercise of the Warrants in accordance with the terms
thereof, shall be fully paid and non-assessable with the Subscriber being entitled to all rights accorded to a holder of Common
Stock. Assuming the accuracy of the representations and warranties of the Subscriber in Section 3.3 hereof, the offer and issuance
by the Company of the Securities is exempt from registration under the Securities Act.

	 

 Section 2.4
SEC Reports.   The Company has filed all reports, schedules, forms, statements and other documents required to
be filed by the Company under the Securities Act and the Securities Exchange Act of 1934, as amended (the “Exchange Act”),
including pursuant to Section 13(a) or 15(d) thereof, for the two years preceding the date hereof (or such shorter period as the
Company was required by law or regulation to file such material) (the foregoing materials, including the exhibits thereto and
documents incorporated by reference therein, being collectively referred to herein as the “SEC Reports”) on a timely
basis or has received a valid extension of such time of filing and has filed any such SEC Reports prior to the expiration of any
such extension.  As of their respective dates, the SEC Reports complied in all material respects with the requirements of
the Securities Act and the Exchange Act, as applicable, and none of the SEC Reports, when filed, contained any untrue statement
of a material fact or omitted to state a material fact required to be stated therein or necessary in order to make the statements
therein, in the light of the circumstances under which they were made, not misleading.  The financial statements of the Company
included in the SEC Reports comply in all material respects with applicable accounting requirements and the rules and regulations
of the Commission with respect thereto as in effect at the time of filing.  Such financial statements have been prepared
in accordance with United States generally accepted accounting principles applied on a consistent basis during the periods involved
(“GAAP”), except as may be otherwise specified in such financial statements or the notes thereto and except that unaudited
financial statements may not contain all footnotes required by GAAP, and fairly present in all material respects the financial
position of the Company and its consolidated subsidiaries as of and for the dates thereof and the results of operations and cash
flows for the periods then ended, subject, in the case of unaudited statements, to normal, immaterial, year-end audit adjustments.

 

Section 2.5 Capitalization.
The Company’s authorized capital consists of 300,000,000 shares of Common Stock and 10,000,000 shares of preferred stock,
undesignated as to series. No shares of preferred stock have been issued or are outstanding.

 

Section 2.6 Use
of Proceeds. The proceeds from the sale of the Securities will be used to commence manufacture of the Company’s NowCardio
and for working capital.

  

ARTICLE III

SUBSCRIBER’S REPRESENTATIONS
AND WARRANTIES

 

The Subscriber hereby
represents and warrants to the Company:

 

Section 3.1 Authorization.
The Subscriber has full power and authority to enter into this Agreement. This Agreement, when executed and delivered by the Subscriber,
will constitute a valid and legally binding obligation of the Subscriber, enforceable in accordance with the terms hereof.

 

Section 3.2 No
Public Sale or Distribution. The Subscriber is acquiring the Securities in the ordinary course of business for its own account
and not with a view towards, or for resale in connection with, the public sale or distribution thereof, except pursuant to sales
registered or exempted under the Securities Act and the Subscriber does not have a present arrangement to effect any distribution
of the Securities, to or through any person or entity. The Subscriber does not presently have any agreement or understanding,
directly or indirectly, with any person to distribute any of the Securities.

 

    	 	

	 

    	 

    

Section 3.3 Regulation
S Exemption. (a) The Subscriber understands that the Securities are being offered and sold in reliance on an exemption from
the registration requirements of United States federal and state securities laws under Regulation S promulgated under the Securities
Act and that the Company is relying upon the truth and accuracy of the representations, warranties, agreements, acknowledgments
and understandings of the Subscriber set forth herein in order to determine the applicability of such exemptions and the suitability
of the Investor to acquire the Securities. In this regard, the Subscriber represents, warrants and agrees that:

(a) The Subscriber
is not a U.S. Person (as defined in the Securities Act) and is not an affiliate (as defined in Rule 501(b) under the Securities
Act) of the Company and is not acquiring the Shares for the account or benefit of a U.S. Person.

 

(b) At
the time of the origination of contact concerning this Agreement and the date of the execution and delivery of this Agreement,
the Subscriber was outside of the United States.

 

(c)The
Subscriber will not, during the period commencing on the date of issuance of the Securities and ending on the first anniversary
of such date, or such shorter period as may be permitted by Regulation S or other applicable securities law (the “Restricted
Period”), offer, sell, pledge or otherwise transfer the Securities in the United States, or to a U.S. Person for the account
or for the benefit of a U.S. Person, or otherwise in a manner that is not in compliance with Regulation S.

 

(d)The
Subscriber will, after expiration of the Restricted Period, offer, sell, pledge or otherwise transfer the Securities only pursuant
to registration under the Securities Act or an available exemption therefrom and, in accordance with all applicable state and
foreign securities laws.

 

(e)The
Subscriber was not in the United States, engaged in, and prior to the expiration of the Restricted Period will not engage in,
any short selling of or any hedging transaction with respect to the Securities, including without limitation, any put, call or
other option transaction, option writing or equity swap.

 

(f)Neither
the Subscriber nor or any person acting on its behalf has engaged, nor will engage, in any directed selling efforts to a U.S.
Person with respect to the Securities and the Subscriber and any person acting on his behalf have complied and will comply with
the “offering restrictions” requirements of Regulation S under the Securities Act.

 

(g)The
transactions contemplated by this Agreement have not been pre-arranged with a buyer located in the United States or with a U.S.
Person, and are not part of a plan or scheme to evade the registration requirements of the Securities Act.

 

(h)Neither
the Subscriber nor any person acting on its behalf has undertaken or carried out any activity for the purpose of, or that could
reasonably be expected to have the effect of, conditioning the market in the United States, its territories or possessions, for
any of the Securities. The Subscriber agrees not to cause any advertisement of the Securities to be published in any newspaper
or periodical or posted in any public place and not to issue any circular relating to the Securities, except such advertisements
that include the statements required by Regulation S under the Securities Act, and only offshore and not in the U.S. or its territories,
and only in compliance with any local applicable securities laws.

 

(i)Each
certificate representing the Securities shall be endorsed with the following legends, in addition to any other legend required
to be placed thereon by applicable federal or state securities laws:

 

(A)“THE
SECURITIES ARE BEING OFFERED TO INVESTORS WHO ARE NOT U.S. PERSONS (AS DEFINED IN REGULATION S UNDER THE SECURITIES ACT OF 1933,
AS AMENDED (“THE SECURITIES ACT”)) AND WITHOUT REGISTRATION WITH THE UNITED STATES SECURITIES AND EXCHANGE COMMISSION
UNDER THE SECURITIES ACT IN RELIANCE UPON REGULATION S PROMULGATED UNDER THE SECURITIES ACT.”

 

    	 	

	 

    	 

    

(B)“TRANSFER
OF THESE SECURITIES IS PROHIBITED, EXCEPT IN ACCORDANCE WITH THE PROVISIONS OF REGULATION S, PURSUANT TO REGISTRATION UNDER THE
SECURITIES ACT, OR PURSUANT TO AVAILABLE EXEMPTION FROM REGISTRATION. HEDGING TRANSACTIONS MAY NOT BE CONDUCTED UNLESS IN COMPLIANCE
WITH THE SECURITIES ACT.”

 

(q) The
Subscriber consents to the Company making a notation on its records or giving instructions to any transfer agent of the Company,
if any, in order to implement the restrictions on transfer of the Securities set forth in this Section.

 

Section 3.4 Reliance
on Exemptions. The Subscriber understands that the Securities are being offered and sold to it in reliance on specific exemptions
from the registration requirements of United States federal and state securities laws and that the Company is relying in part
upon the truth and accuracy of, and the Subscriber's compliance with, the representations, warranties, agreements, acknowledgments
and understandings of the Subscriber set forth herein in order to determine the availability of such exemptions and the eligibility
of the Subscriber to acquire the Securities. Further, if this transaction is not being conducted in accordance with Regulation
S and Subscriber is an accredited investor, in lieu of the legends set forth above, the certificates representing the Securities
will have a restrictive “Securities Act” legend imprinted thereon

 

Section 3.5 Information.
The Subscriber has been furnished with or has had access at the EDGAR Website of the Securities and Exchange Commission to the
SEC Reports.  In addition, the Subscriber has received in writing from the Company such other information concerning its
operations, financial condition and other matters as the Subscriber has requested in writing and considered all factors the Subscriber
deems material in deciding on the advisability of investing in the Securities. Subscriber has carefully read, and understands
the information in the SEC Reports. Neither such inquiries nor any other due diligence investigations conducted by the Subscriber
or its advisors, if any, or its representatives shall modify, amend or affect the Subscriber's right to rely on the Company's
representations and warranties contained herein. The Subscriber understands that its investment in the Securities involves a high
degree of risk and is able to afford a complete loss of such investment. The Subscriber has sought such accounting, legal and
tax advice as it has considered necessary to make an informed investment decision with respect to its acquisition of the Securities.

 

 

ARTICLE IV

MISCELLANEOUS

 

Section 4.1 Governing
Law; Jurisdiction and Venue. This Agreement shall be governed by and construed in accordance with the laws of the State of
New York without regard to principles of conflicts of laws. Any action brought by either party against the other concerning the
transactions contemplated by this Agreement shall be brought only in the state courts of New York or in the federal courts located
in the state and county of New York. The parties to this Agreement hereby irrevocably waive any objection to jurisdiction and
venue of any action instituted hereunder and shall not assert any defense based on lack of jurisdiction or venue or based upon
forum non conveniens. The Company and Subscriber waive trial by jury. The prevailing party shall be entitled to recover
from the other party its reasonable attorney's fees and costs.  In the event that any provision of this Agreement or any other
agreement delivered in connection herewith is invalid or unenforceable under any applicable statute or rule of law, then such
provision shall be deemed inoperative to the extent that it may conflict therewith and shall be deemed modified to conform with
such statute or rule of law. Any such provision which may prove invalid or unenforceable under any law shall not affect the validity
or enforceability of any other provision of any agreement. Each party hereby irrevocably waives personal service of process and
consents to process being served in any suit, action or proceeding in connection with this Agreement by mailing a copy thereof
via registered or certified mail or overnight delivery (with evidence of delivery) to such party at the address in effect for
notices to it under this Agreement and agrees that such service shall constitute good and sufficient service of process and notice
thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any other manner permitted
by law.

 

Section 4.2 Entire Agreement;
Amendments. This Agreement (including the exhibits and schedules annexed hereto) contains the entire understanding of the
parties with respect to the matters covered herein and therein and, except as specifically set forth herein or therein, neither
the Company nor the Subscriber makes any representation, warranty, covenant or undertaking with respect to such matters. No provision
of this Agreement may be waived or amended other than by an instrument in writing signed by the parties.

 

    	 	

	 

    	 

    

Section 4.3 Notices.
All notices, demands, requests, consents, approvals, and other communications required or permitted hereunder shall be in writing
and, unless otherwise specified herein, shall be (i) personally served, (ii) delivered by reputable air courier service with charges
prepaid, or (iii) transmitted by electronic mail with a copy sent by overnight courier, addressed as set forth below or to such
other address as such party shall have specified most recently by written notice. Any notice or other communication required or
permitted to be given hereunder shall be deemed effective (a) upon hand delivery or delivery by electronic mail (assuming the
courier copy is also served), at the address designated below (if delivered on a business day during normal business hours where
such notice is to be received), or the first business day following such delivery (if delivered other than on a business day during
normal business hours where such notice is to be received) or (b) on the second business day following the date of mailing by
express courier service, fully prepaid, addressed to such address, or upon actual receipt of such mailing, whichever shall first
occur. The addresses for such communications shall be:

 

If
to the Company:

EVENT
CARDIO GROUP INC.

7694
Colony Palm Drive

Boynton
Beach, Florida 33436

Attn:
John Bentivoglio

Chief
Executive Officer

e-mail:
johnb@eventcardiogroup.com.

 

If to the Subscriber: to the address specified on the signature
page hereof.

 

Each party shall provide notice to the other party of any
change in address.

 

Section 4.4 No
Broker of Finder. Each party represents and warrants to the other that no person or entity is entitled to any broker’s
finder’s or similar fee in connection with the transaction contemplated hereby.

 

Section 4.5 Successors and Assigns.  This
Agreement shall be binding upon and inure to the benefit of the parties and their successors and assigns.  Neither the Company
nor the Subscriber shall assign this Agreement or any rights or obligations hereunder without the prior written consent of the
other.

 

Section 4.6 Third Party
Beneficiaries. This Agreement is intended for the benefit of the parties hereto and their respective permitted successors
and assigns, and is not for the benefit of, nor may any provision hereof be enforced by, any other person.

 

Section 4.7 Severability.
In the event that any provision of this Agreement is invalid or unenforceable under any applicable statute or rule of law, then
such provision shall be deemed inoperative to the extent that it may conflict therewith and shall be deemed modified to conform
with such statute or rule of law. Any provision hereof which may prove invalid or unenforceable under any law shall not affect
the validity or enforceability of any other provision hereof.

 

Section 4.8 Counterparts.
This Agreement may be executed in one or more counterparts, each of which shall be deemed an original but all of which shall constitute
one and the same agreement and shall become effective when counterparts have been signed by each party and delivered to the other
party.

 

 

Section 4.9 Headings.
The headings of this Agreement are for convenience of reference only and shall not form part of, or affect the interpretation
of, this Agreement.

 

 

 

[Signature Page is on the Following
Page]

    	 

    	 

    

 

Signature Page to Subscription Agreement

	 

IN WITNESS WHEREOF,
the parties have executed this Agreement as of the date set forth above.

 

 EVENT
CARDIO GROUP, INC.

 

 

By:
/s/ John Bentivoglio

John
Bentivoglio

President
and CEO

 

/s/Zhenli
Xu

Zhenli
Xu

 

 

Address:
3-120 Dianye Avenue

Economic
Development Zone

Weifang,
Shangdong

China
261000

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00259-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00259-of-00352.parquet"}]]